14Feb/13

US FDA grants "breakthrough" status for Janssen and Pharmacyclics ibrutinib – The Pharma Letter

US FDA grants “breakthrough” status for Janssen and Pharmacyclics ibrutinib
The Pharma Letter
A Phase III randomized, multi-center registration trial of ibrutinib as a monotherapy versus temsirolimus in relapsed or refractory MCL patients who received at least one prior rituximab-containing chemotherapy regimen, RAY (MCL3001). • A Phase III

14Feb/13

Doctors urge move to 'opt-out' organ donor system in Scotland – The Courier


ITV News

Doctors urge move to ‘opt-out’ organ donor system in Scotland
The Courier
The BMA is also urging more Scots to sign up to the Organ Donor Register and to discuss their wishes with friends and family. Ms Hollis said: “It is vital that people talk to their loved ones about their wishes and discuss openly their views on organ
From the Heart: Organ Donation around the WorldITV News
Alexandra Burke – Stars Boost Awareness Of Organ Donor Drive With Tv SpecialContactmusic.com
New campaign hopes to get people talking about organ donationstv.tv
Health24.com –TopNews New Zealand –ParamusPost.com
all 17 news articles »
14Feb/13

Theradiag's new biotherapy monitoring kits receive CE mark approval – News-Medical.net

Theradiag’s new biotherapy monitoring kits receive CE mark approval
News-Medical.net
Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostic and in vitro diagnostics, today announced it has obtained a CE mark for two new biotherapy monitoring kits; Tocilizumab (anti-IL6R) and Rituximab (anti-CD20) that

and more »